Explained herein are pharmaceutical packaging programs which reduce oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate medicine, these kinds of systems including a syringe using an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister pac